技術指標
指標
數值
方向
MACD(12,26,9)
-1.479
中性
RSI(14)
66.603
中性
STOCH(KDJ)(9,3,3)
69.298
中性
ATR(14)
5.495
低波動
CCI(14)
83.413
中性
Williams %R
22.754
買入
TRIX(12,20)
0.403
賣出
StochRSI(14)
33.180
賣出
搜尋
DaVita Inc
DVA添加自選
240.090USD
+1.260+0.53%
收盤 07-31 16:00（美東）報價延遲15分鐘
16.46B總市值
21.95本益比TTM
關鍵數據
237.810今開
240.910最高
426.61K成交量
21.95本益比TTM
16.16本益比動
--股利TTM
0.62%換手率
238.860昨收
236.085最低
44.26M成交額
17.58本益比靜
-25.28市淨率
0.00%股息率 TTM
6.33%ROA
202.69052週最高
0.74量比
936.34M淨利潤
68.55M總股本
10.9395每股盈餘TTM
0.90Beta
635.30%ROE
101.00052週最低
2.02%振幅
26.22%毛利率
16.46B總市值
0.88回報/風險
1.91%風險率
TradingKey DaVita Inc股票評分
單位: USD 更新時間: 2026-07-31操作建議
DaVita Inc當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在醫療服務供應商行業排名28/75位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為208.59。中期看，股價處於上升通道。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
DaVita Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
7°C
過冷
過熱
中性
DaVita Inc亮點
亮點風險
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
估值高估
公司最新PE估值21.95，處於3年歷史高位
機構減倉
最新機構持股36.02M股，環比減少8.30%
華倫‧巴菲特持倉
明星投資者華倫‧巴菲特持倉，最新持倉23.75M股
活躍度降低
近期活躍度降低，過去20天平均換手率-0.16
分析師目標
基於
9
分析師
持有
評級
208.587
目標均價
-13.43%
漲幅空間
DaVita Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
9
分析師
持有
評級
208.587
目標均價
-13.43%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
58
總數
9
中位數
10
平均值
公司名稱
評級分佈
分析師數
DaVita Inc
DVA
9
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
技術指標
移動平均線
指標
數值
方向
MA5
239.136
買入
MA10
236.885
買入
MA20
235.123
買入
MA50
216.864
買入
MA100
188.652
買入
MA200
156.649
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
DaVita Inc簡介
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代碼DVA
公司DaVita Inc
CEORodriguez (Javier J)
網址https://www.davita.com/
公司股東
相關品種
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
DaVita Inc(DVA)的當前股價是多少？
DaVita Inc(DVA)的當前股價是 240.23。
DaVita Inc 的股票代碼是什麼？
DaVita Inc的股票代碼是DVA。
DaVita Inc股票的52週最高點是多少？
DaVita Inc股票的52週最高點是202.69。
DaVita Inc股票的52週最低點是多少？
DaVita Inc股票的52週最低點是101.00。
DaVita Inc的市值是多少？
DaVita Inc的市值是16.47B。
現在DaVita Inc(DVA)的股票是買入、持有還是賣出？
根據分析師評級，DaVita Inc(DVA)的總體評級為signal_hold，目標價格為208.59。
DaVita Inc(DVA)股票的每股收益（EPS TTM）是多少
DaVita Inc(DVA)股票的每股收益（EPS TTM）是10.06。